New Zealand - English - Medsafe (Medicines Safety Authority)

viatris limited - estradiol hemihydrate 0.82mg - transdermal patch - 50 mcg/24h - active: estradiol hemihydrate 0.82mg excipient: acrylic adhesive dipropylene glycol oleyl alcohol pegoterate polyolefin povidone silicone adhesive - estradiol is indicated for the following: - oestrogen replacement therapy for the treatment of the symptoms of natural or surgically induced menopause. - prevention of postmenopausal osteoporosis.

New Zealand - English - Medsafe (Medicines Safety Authority)

viatris limited - estradiol hemihydrate 1.23mg - transdermal patch - 75 mcg/24h - active: estradiol hemihydrate 1.23mg excipient: acrylic adhesive dipropylene glycol oleyl alcohol pegoterate polyolefin povidone silicone adhesive - estradiol is indicated for the following: - oestrogen replacement therapy for the treatment of the symptoms of natural or surgically induced menopause. - prevention of postmenopausal osteoporosis.

New Zealand - English - Medsafe (Medicines Safety Authority)

inova pharmaceuticals (new zealand) limited - estradiol 0.312 mg/cm² equivalent to 100 µg/24h;   - transdermal patch - 100 mcg/24h - active: estradiol 0.312 mg/cm² equivalent to 100 µg/24h   excipient: ethyl acetate ethyl oleate glyceryl monolaurate isopropyl myristate methanol polyethylene

New Zealand - English - Medsafe (Medicines Safety Authority)

inova pharmaceuticals (new zealand) limited - estradiol 0.312 mg/cm² equivalent to 50 µg/24h;   - transdermal patch - 50 mcg/24h - active: estradiol 0.312 mg/cm² equivalent to 50 µg/24h   excipient: ethyl acetate ethyl oleate glyceryl monolaurate isopropyl myristate methanol polyethylene

Israel - English - Ministry of Health

bayer israel ltd - dienogest; dienogest; estradiol valerate; estradiol valerate; estradiol valerate - film coated tablets - estradiol valerate 1 mg; estradiol valerate 3 mg; dienogest 2 mg; dienogest 3 mg; estradiol valerate 2 mg - estradiol - estradiol - oral contraception.treatment of heavy menstrual bleeding in women without organic pathology who desire oral contraception.

Ireland - English - HPRA (Health Products Regulatory Authority)

rottapharm ltd - estradiol - transdermal patch - 50 microgram(s)/24 hours - natural and semisynthetic estrogens, plain; estradiol

Ireland - English - HPRA (Health Products Regulatory Authority)

rottapharm ltd - estradiol - transdermal patch - 25 microgram(s)/24 hours - natural and semisynthetic estrogens, plain; estradiol

United States - English - NLM (National Library of Medicine)

alvogen, inc. - estradiol (unii: 4ti98z838e) (estradiol - unii:4ti98z838e) - estradiol 0.025 mg in 1 d -     when prescribing solely for the treatment of moderate to severe symptoms of vulvar and vaginal atrophy due to menopause, topical vaginal products should be considered.     when prescribing solely for the prevention of postmenopausal osteoporosis, therapy should only be considered for women at significant risk of osteoporosis and non-estrogen medication should be carefully considered. the estradiol transdermal system is contraindicated in women with any of the following conditions: the estradiol transdermal system should not be used during pregnancy [see contraindications (4)] . there appears to be little or no increased risk of birth defects in children born to women who have used estrogens and progestins as oral contraceptives inadvertently during early pregnancy. the estradiol transdermal system should not be used during lactation. estrogen administration to nursing women has been shown to decrease the quantity and quality of the breast milk. detectable amounts of estrogens have been identified in the b

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

sandoz ltd - estradiol - transdermal patch - 25microgram/24hour

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

sandoz ltd - estradiol - transdermal patch - 37.5microgram/24hour